Medasense Biometrics Ltd.

📍 Ramat Gan, Israel🗓 Founded 2008👥 29 employees💰 Last funded May 2020
Medasense is transforming the way PAIN is being assessed and treated worldwide. Through our breakthrough NOL® AI technology and sensing platform, we quantify pain response to optimize care and avoid overmedication. Medasense’s flagship product, PMD-200™, is used in critical care settings, where patients are unable to communicate, to visualize pain response and personalize treatment. Clinical studies have demonstrated its impact on patient safety and outcomes – including opioid sparing and lower pain scores reported by patients. PMD-200™ is distributed in Europe by Medtronic, and is also commercially available in Canada, Latin America, Israel, Australia and the United Arab Emirates. It enables connectivity with Philips and Mindray patient monitors. Along our path to improve pain care in additional settings, we are harnessing our AI capabilities with NOLedge™, an agile investigational device to lead prediction, stratification and prevention strategies that will enable better pain management and reduce healthcare expenditures.
3
Total investors
0
Early stage
0
Mid stage
1
Late stage
2008
Founded
Investor geography2 countries
Israel
2
Spain
1
Investor activity2014–2020 · investors recorded per year
2014120202
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Medasense Biometrics Ltd.?
Medasense Biometrics Ltd. has 3 investors on record on gritt.io and 1 late-stage investors.
When did Medasense Biometrics Ltd. last raise funding?
The most recent investment in Medasense Biometrics Ltd. recorded on gritt.io was in May 2020.
When was Medasense Biometrics Ltd. founded?
Medasense Biometrics Ltd. was founded in 2008.
What industry is Medasense Biometrics Ltd. in?
Medasense Biometrics Ltd. operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is Medasense Biometrics Ltd. based?
Medasense Biometrics Ltd. is headquartered in Ramat Gan, Israel.